Transfusion therapy

The New England Journal of Medicine


No abstract listed.


Jan 1, 1954·American Journal of Clinical Pathology·M B ZUCKER
Jul 31, 1954·British Medical Journal·H C MOORE
Nov 1, 1954·Canadian Journal of Biochemistry and Physiology·J B ARMSTRONGH R WILLIAMS
Jan 1, 1955·British Journal of Haematology·R BIGGSG RICHARDS
Dec 1, 1957·American Journal of Clinical Pathology·J G GIBSONW A SCHEITLIN
Apr 26, 1958·Journal of the American Medical Association·W N TAUXE, T B MAGATH
Aug 30, 1958·British Medical Journal·J LUDBROOK, V WYNN
Nov 29, 1958·Journal of the American Medical Association·W A SAYMANJ G ALLEN
Dec 13, 1958·Journal of the American Medical Association·A W ULINE W EHRLICH
Feb 1, 1959·The American Journal of Medicine·R B FINKBINERJ P BUNKER
Apr 1, 1959·American Journal of Clinical Pathology·S I RAPAPORTS MIKKELSEN
Mar 1, 1961·Transfusion·H B ANSTALLR S SHAW
Sep 29, 1960·The New England Journal of Medicine·J G GIBSONT J McMANUS
Jul 1, 1959·Journal of Clinical Pathology·J P SOULIER
May 1, 1955·Journal of Applied Physiology·W H SEEGERSS A JOHNSON
Jul 7, 1955·The New England Journal of Medicine·M F LESSES, H J BANTON
Jul 30, 1955·British Medical Journal·J S SCOTT
Jan 1, 1955·Acta Medica Scandinavica·U JACOBAEUS
Aug 13, 1960·JAMA : the Journal of the American Medical Association·L L HAYNESW C TURVILLE
Jul 21, 1960·The New England Journal of Medicine·W B NEPTUNEF G PANICO
Aug 11, 1960·The New England Journal of Medicine·S I RAPAPORTJ R GOODMAN
Sep 6, 1951·The New England Journal of Medicine·L SOUTTERC P EMERSON
Jun 7, 1952·Nature·C R RICKETTS
Oct 7, 1948·The New England Journal of Medicine·S T GIBSON
Oct 25, 1947·Journal of the American Medical Association·A M WOLF, J MASON
Aug 24, 1940·British Medical Journal·J W MagladeryC H Best

❮ Previous
Next ❯


Jan 1, 1985·Aesthetic Plastic Surgery·C O UebelJ Bahlis
Mar 1, 1965·The Bulletin of Mathematical Biophysics·R P SPENCER
Jan 1, 1964·Bibliotheca Haematologica·H F POLESKY, J R BOVE
Sep 1, 1963·Transfusion·K IWATSUKIM INAGAKI
Nov 1, 1970·Transfusion·A J Katz, R C Tilton
Jul 1, 1964·Transfusion·H F POLESKY, J R BOVE
Jan 1, 1963·Transfusion·J W REBUCK

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.